Nonopioid pharmacological management of acute low back pain: A level I of evidence systematic review
Open Access
- 22 February 2023
- journal article
- review article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 41 (8) , 1781-1791
Abstract
Acute low back pain (LBP) imposes a significant socioeconomical burden as it is the condition that, worldwide, cause the most disability. Nonetheless, the literature regarding the best pharmacological management of acute LBP is limited, and the indications available in the literature are conflicting. This work investigates whether the pharmacological management of acute LBP can effectively reduce pain and disability, and aims to identify which drugs show the highest efficacy. This systematic review was conducted according to the 2020 PRISMA statement. In September 2022, PubMed, Scopus, and Web of Science were accessed. All the randomized controlled trials investigating the efficacy of myorelaxants, nonsteroidal anti‐inflammatory drugs (NSAIDs), and paracetamol for acute LPB were accessed. Only studies that investigated the lumbar spine were included. Only studies reporting on patients with acute LBP with symptom duration of less than 12 weeks were included. Only patients older than 18 years and with nonspecific low back pain were included. Studies that investigated the use of opioids in acute LBP were not considered. Data from 18 studies and 3478 patients were available. Myorelaxants and NSAIDs were effective in reducing pain and disability in acute LBP at approximately one week. The combination of NSAIDs and paracetamol was associated with a greater improvement than the use of NSAIDs alone, but paracetamol alone did not induce any significant improvement. Placebo was not effective in reducing pain. Clinical Significance: Myorelaxants, NSAIDs, and NSAIDs with paracetamol could reduce pain and disability in patients with acute LBP.Keywords
This publication has 47 references indexed in Scilit:
- Interventions Available Over the Counter and Advice for Acute Low Back Pain: Systematic Review and Meta-AnalysisThe Journal of Pain, 2014
- Expectations about recovery from acute non-specific low back pain predict absence from usual work due to chronic low back pain: a systematic reviewJournal of Physiotherapy, 2012
- The prognosis of acute and persistent low-back pain: a meta-analysisCanadian Medical Association Journal, 2012
- The Epidemiology of low back painBest Practice & Research Clinical Rheumatology, 2010
- Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasmCurrent Medical Research and Opinion, 2008
- Back Pain Prevalence and Visit RatesSpine, 2006
- Chapter 4 European guidelines for the management of chronic nonspecific low back painEuropean Spine Journal, 2006
- Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back painInternational Journal Of Clinical Practice, 2005
- Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back painJoint Bone Spine, 2003
- Acute Severe Low Back PainSpine, 1996